对不同胃病患者的Helicobacter pylori耐药性的分析
Yongfu Shao1,2, Yifan Lin3, Ziyi Fang1,2
1Health Science Center, Ningbo University, Ningbo, 315211, China.
Scientific reports
|February 28, 2024
概括
杆菌 (H. pylori) 的抗生素耐药性是治疗失败的主要原因之一. 这项研究发现,缩性胃炎,老年和使用质子抑制剂 (PPI) 会增加H. pylori耐药感染的风险.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 微生物学 微生物学
背景情况:
- Helicobacter pylori (H. pylori) 的抗生素耐药性是一个重大的全球健康问题,直接影响了根除成功率.
- 了解区域和特定疾病的耐药性模式对于有效的H. pylori治疗策略至关重要.
- 有限的数据存在于H. pylori在各种胃粘膜病变中的抗生素耐药性.
研究的目的:
- 分析H. pylori抗生素耐药性趋势和个人资料,与患者人口统计和胃病相关.
- 为了研究质子抑制剂 (PPI) 史对H. pylori抗生素耐药性的影响.
- 开发一种临床H. pylori抗生素耐药性风险的预测模型.
主要方法:
- 这是一项长达8年的回顾性队列研究,涉及2847名患者.
- 对H.pylori对阿莫西西林 (AMX),克拉里胺素 (CLR),勒沃素 (LVX) 和法拉佐利 (FR) 的耐药性率的分析.
- 评估单药和多药耐药性模式,以及与胃病变,年龄,性别和PPI使用的关联.
主要成果:
- 整体阻力率:AMX 8.18%,CLR 38.11%,LVX 43.98%,FR 13.73%. 这是一个很大的问题.
- 单抗,双抗,三抗和四抗的阻力率分别为30.17%,25.96%,6.46%和0.63%.
- 在过去5年观察到的单抗和多抗下降趋势;缩性胃炎,年龄较大和PPI史被确定为耐药H. pylori感染的高风险因素.
结论:
- 性胃炎是高风险H. pylori抗生素耐药性的关键临床指标.
- 患者的年龄,性别,胃病变类型和最近的PPI治疗史与H. pylori抗生素耐药性有关.
- 这些发现凸显了缩性胃炎患者中耐药H. pylori感染的风险增加,PPI使用史和年龄较大.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
397
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
397
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
117
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
117
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
429
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
429
Peptic Ulcer Disease I: Introduction
168
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
168
Gastritis-II: Pathophysiology
326
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
326
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
591
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
591


